Dianomi LogoWebMD Logo

Publisher Inventory Monetisation & Yield · vs · Healthcare Media & Clinician Networks

Dianomi vs WebMD

Structured technology and market comparison · 2026

Direct Feature Comparison

Dianomi · vs · WebMD
Direct Feature Comparison: Dianomi vs WebMD
Attribute
Dianomi LogoDianomi
WebMD LogoWebMD
Market Cluster / SectorPublisher Inventory Monetisation & YieldHealthcare Media & Clinician Networks
Business Model / RoleAdTech VendorPublisher & Media Owner · B2B SaaS Provider
Platform FocusPremium native advertising marketplace for advertisers and publishers.Digital health publisher with healthcare advertising and audience targeting assets.
Company Size10–49 employees1,001–5,000 employees
HeadquartersUnited KingdomUnited States
Year Founded20021998
Dossier & Alternatives

Analyze all overlapping signals and tech stacks for Dianomi and WebMD

Compare mutual enterprise clients, monetization models, live market signals, and partner networks directly in the interactive Knowledge Graph.

Compare in PlatformInstant access · 1-click via Google/LinkedIn

Comparison Analysis

What is the main difference between Dianomi and WebMD?

When comparing Dianomi and WebMD, both platforms operate within the Self-Serve Ad Platform, In-App, and Native & Contextual Ads ecosystem. Dianomi is positioned as Premium native advertising marketplace for advertisers and publishers, whereas WebMD focuses on Digital health publisher with healthcare advertising and audience targeting assets. Decision-makers evaluate both solutions when orchestrating their commercial monetization and technology stack.

What are the top alternatives to Dianomi and WebMD?

When evaluating Dianomi and WebMD, enterprise buyers also consider other platforms in Self-Serve Ad Platform, In-App, and Native & Contextual Ads. You can discover the full competitive landscape and evaluate other alternatives by viewing their respective footprint profiles on Polaris7.

How do the corporate scale, structure, and headquarters of Dianomi and WebMD compare?

Dianomi is headquartered in United Kingdom (founded in 2002) with 10–49 employees. WebMD is based in United States (founded in 1998) with 1,001–5,000 employees. Complete ownership, subsidiary trees, and corporate affiliations are documented across Polaris7.

Market Signals

Recent Market Signals & Activity: Dianomi vs WebMD

Documented market movements, strategic partnerships, product releases, and regulatory developments mapped across Polaris7.

Dianomi Logo

Dianomi

Recent Signals

  • ·TaboolaM&A & Corporate Finance

    Taboola Finalizes Acquisition of Dianomi

    Taboola (Nasdaq: TBLA) announced on November 16, 2026 that it has completed its previously announced acquisition of Dianomi, a provider of digital advertising services for premium clients in the business, finance, and lifestyle sectors. The deal bolsters Taboola's Realize performance advertising platform, which leverages proprietary supply, first-party data, and AI to deliver scalable outcomes. Dianomi connects blue-chip advertisers such as Charles Schwab, Invesco, and Bank of America with high-intent audiences via publishers including Reuters, CNN Business, and WSJ, and is trusted by over 600 advertisers and publishers. Taboola's CEO Adam Singolda highlighted the combined network's value for advertisers seeking high-intent finance audiences and for publishers seeking deeper blue-chip advertiser relationships.

    • Taboola completed its acquisition of Dianomi on November 16, 2026.
    • Dianomi is a digital advertising provider for premium clients in business, finance, and lifestyle sectors.
    • The acquisition enhances Taboola's Realize platform with a specialized finance-focused ad network.
  • ·AdExchangerAcquisitions

    AdExchanger Podcast: Infillion-Foursquare, Taboola-Dianomi, WarnerMount Merger

    This AdExchanger podcast episode discusses two ad tech acquisitions from last Friday: Infillion's acquisition of Foursquare, adding location data to its ad tech stack, and Taboola's acquisition of Dianomi, targeting the finance vertical. Editor-in-Chief Allison Schiff provides rationale and potential synergies. The episode also covers the Warner Bros.-Paramount merger, now dubbed 'WarnerMount', as the major antitrust hurdle was resolved when California and 11 other states settled their lawsuit. Paramount had threatened to leave California, which pressured the settlement. A new legal challenge emerged but is seen as less formidable. The discussion highlights the strategic moves in ad tech consolidation and the significant regulatory scrutiny on major media mergers.

    • Infillion acquired Foursquare, adding location data to its ad tech stack.
    • Taboola made an offer to acquire ad network Dianomi to target the finance vertical.
    • California and 11 other states settled an antitrust lawsuit against the Warner Bros.-Paramount merger.
  • ·AdExchangerM&A

    Taboola Offers to Acquire Finance Ad Network Dianomi

    Taboola has made an offer to acquire Dianomi, a UK-based ad tech company specializing in connecting financial advertisers with premium business and finance publishers. The deal includes a cash component and potential earnout provisions, valuing Dianomi between £19 million and £27 million (roughly $25-$36 million). The acquisition is expected to close before the end of 2026, pending regulatory approval and a shareholder vote. Dianomi's publisher partners include Reuters, CNN Business, The Wall Street Journal, and The Times, with advertiser clients like Charles Schwab and Bank of America. Taboola plans to integrate Dianomi into its Realize performance advertising platform, expanding its supply side and reach into the finance vertical. The article also notes that 33Across rebranded to WealthStage the same week, indicating a broader industry trend toward vertical specialization in financial services advertising.

    • Taboola has made an offer to acquire Dianomi, a UK-based finance-focused ad network.
    • The deal values Dianomi between £19 million and £27 million (roughly $25-$36 million).
    • The acquisition is expected to close before the end of 2026, subject to regulatory approval and shareholder vote.
WebMD Logo

WebMD

Recent Signals

No recent market signals documented for WebMD in the current tracking window.

Start with a company or market. Track what changes.

Create your Polaris7 workspace to explore extended company profiles, organize relevant players into Watchlists, and receive focused briefings when material changes occur.